101 related articles for article (PubMed ID: 20373995)
1. Soluble angiogenesis factors in sera of Egyptian patients with hepatitis C virus infection: correlation with disease severity.
Talaat RM
Viral Immunol; 2010 Apr; 23(2):151-7. PubMed ID: 20373995
[TBL] [Abstract][Full Text] [Related]
2. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
3. Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma.
Talaat RM; Salem TA; El-Masry S; Imbarek A; Mokhles M; Abdel-Aziz A
J Med Virol; 2014 Jul; 86(7):1120-9. PubMed ID: 24677137
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of TNF a mRNA and VEGF mRNA expression in patients with chronic hepatitis C genotype-4, with and without cirrhosis and hepatocellular carcinoma to predict disease outcome.
Kishta SA; Abd-Alhade AA; Hamam O; Raoof EA; Abeya S
J Egypt Soc Parasitol; 2010 Aug; 40(2):515-30. PubMed ID: 21246958
[TBL] [Abstract][Full Text] [Related]
5. [Growth factors in chronic hepatitis C].
Panasiuk A; Pogorzelska J; Prokopowicz D
Przegl Epidemiol; 2007; 61(3):559-66. PubMed ID: 18069394
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804
[TBL] [Abstract][Full Text] [Related]
8. IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study.
Kao JT; Feng CL; Yu CJ; Tsai SM; Hsu PN; Chen YL; Wu YY
BMC Gastroenterol; 2015 Apr; 15():50. PubMed ID: 25908103
[TBL] [Abstract][Full Text] [Related]
9. Correlation between angiogenic/inflammatory mediators in Wister rat model of liver dysplasia.
Talaat RM; Adel S; Salem TA; Nasr MI
J Immunoassay Immunochem; 2016; 37(5):472-84. PubMed ID: 27177216
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran.
Shamsdin SA; Mehrafshan A; Rakei SM; Mehrabani D
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2883-2890. PubMed ID: 31653130
[TBL] [Abstract][Full Text] [Related]
11. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
12. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
14. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
15. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
Huang YS; Hwang SJ; Chan CY; Wu JC; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):327-33. PubMed ID: 10389289
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus Associations with Non Hodgkin's Lymphoma: Insights on Inflammation/Angiogenesis and CD Markers.
El-Maadawy EA; Talaat RM; Sadek RF; El-Sherbini SM; Abdel-Bary N; Abdel-Aziz AA
Asian Pac J Cancer Prev; 2016; 17(9):4415-4420. PubMed ID: 27797254
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
[TBL] [Abstract][Full Text] [Related]
20. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
